Trials / Not Yet Recruiting
Not Yet RecruitingNCT06290440
MEdication Counselling Models for Outpatient oRal antIcoaguLation
Development of Medication Counselling Models for Outpatient Oral Anticoagulant-taking Patients
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Gia Dinh People Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to investigate whether telepharmacy-led counselling can improve medication adherence, knowledge, and hospitalisation/mortality compared with pharmacist-led counselling in adult outpatients taking oral anticoagulants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Telepharmacy-led counselling | The counselling process will be delivered as follows: (1) researchers assist patients in signing up and using the telepharmacy application; (2) researchers send the counselling information from the telepharmacy application to the patient's account (the information will be provided as leaflets and 3-5-minute videos to improve the accessibility); (3) the integrated chatbot system forwards any additional questions or concerns of the patients to the counselling pharmacists; and (4) the pharmacists directly address the patient's questions or concerns through phone calls within the shortest possible timeframe. |
| OTHER | Pharmacist-led counselling | Pharmacists will counsel the patients on how to use their OAC. Each counselling section will take approximately 7-15 minutes, depending on the patient's questions or concerns. The counselling contents have already been compiled and validated by NDGD Hospital to ensure rationale and simplicity for every patient. Counselling pharmacists have received specialised training in drug information and patient communication so intervention delivery will be consistent across different pharmacists. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-12-01
- Completion
- 2026-12-01
- First posted
- 2024-03-04
- Last updated
- 2024-03-06
Source: ClinicalTrials.gov record NCT06290440. Inclusion in this directory is not an endorsement.